Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients

europeanpharmaceuticalreviewApril 06, 2020

Tag: COVID-19 , Avigan , Fujifilm

PharmaSources Customer Service